Where: Sir Michael Uren Hub, White City Campus
When: Tuesday 16 September | 9:30-17:15
For any queries, please email: k.glasgow@imperial.ac.uk
Programme
9:30: Registration
9:50: Opening – Introduction and welcome
Professor Chris Chiu, Professor of Infectious Diseases, Director of INVaR
9:55: Keynote Address: How effective RSV vaccines were developed and licensed
Phil Dormitzer, Founder and President, Dormitzer Biologics Inc.
Former Chief Scientific Officer for Viral and RNA Vaccines, Pfizer & Global Head of Vaccines R&D, GSK
10:15: Imperial’s strategic vision for vaccine research
Professor Robin Shattock, Professor of Mucosal Infection and Immunity
10:20: Session 1: Underpinning biology for vaccine development (Chair TBC)
- Pietro Sormanni, Royal Society University Research Fellow, Department of Chemical Engineering
Antibody discovery and engineering by computational design - Rahwa Osman, Research Associate, Department of Life Sciences
Towards a new era of malaria vaccines - Kostas Paschos, Research Associate, Department of Infectious Disease
Monoclonal B cell culture system for rapid isolation of vaccine-induced neutralising monoclonal antibodies - Alice Denton, Associate Professor, Department of Immunology and Inflammation
Understanding how vaccines alter the immune landscape to initiate the GC response - Fadil Bidmos, Proleptic Associate Professor in Bacterial Vaccinology, Department of Infectious Disease
Next-generation bacterial vaccine antigen discovery
11:35: Break & poster viewing
11:55: Session 2: Translating breakthrough science into vaccine solutions (Chair TBC)
- Andre Ohara, Research Associate, Department of Chemical Engineering
Integrated automation and secretion pathway optimization for glycoprotein vaccine production in Pichia pastoris - Simon Daniel, Research Postgraduate, Department of Chemical Engineering
Platform process model to ensure RNA vaccine quality - Rongjun Chen, Professor of Biomaterials Engineering, Department of Chemical Engineering
Bio-inspired nanostructures for enhanced RNA delivery and long-term thermostability - Tiago Dias da Costa, Associate Professor in Bacterial Pathogenesis, Department of Life Sciences
Bacterial scaffolds for antigen display - Talia Shmool, Research Fellow, Department of Chemical Engineering
RNA-lipid nanoparticles with defined delivery profiles and prolonged stability
13:10: Lunch
14:10: Session 3: Accelerating evaluation and delivery of vaccines (Chair TBC)
- Helen Skirrow, Clinical Research Fellow, School of Public Health
‘I’m not anti-vaccines but I have questions’, using co-production research to address childhood vaccine uptake inequalities - Malick Gibani, Clinical Associate Professor of Bacterial Vaccinology, Department of Infectious Disease
Vaccines for invasive non-typhoidal Salmonella – Can vaccine development be accelerated using a human challenge model? - Nieves Derqui, Research Postgraduate, School of Public Health
Routine immunisation trends and vaccination inequalities: analysis of survey data from LMICs - Helen Wagstaffe, Research Associate, Department of Infectious Disease
Human challenge studies for the evaluation of SARS-CoV-2 mucosal vaccines - Emanuele Nolfi, Research Assistant, Department of Infectious Disease
An saRNA-based strategy for early-stage group A streptococcal vaccine discovery
15:25: Break & poster viewing
15:50: Session 4: Breakout exercise – What should be the future for vaccine research at Imperial
Professor Robin Shattock, Professor of Mucosal Infection and Immunity (Chair)
- Aim: To engage with Imperial investigators to set out our priorities for vaccine research over the next 5-10 years and plan for their delivery
- Key questions:
- What do you think the Centre can/should do for your research in the next five years?
- How do you propose the Centre provides the support you need to achieve this?
16:40: Feedback from Session 4
Professor Robin Shattock, Professor of Mucosal Infection and Immunity (Chair)
17:00: Closing remarks and presentation of poster prizes